Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma
Frontiers in Oncology · 01.07.2026 · 16
DOI: 10.3389/fonc.2026.1850083 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 01.07.2026. Verfasst von Yuke Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Urothelial carcinoma of the bladder (UBC) and upper tract urothelial carcinoma (UTUC) are distinct malignancies with differing prognoses and molecular characteristics despite their shared histological origin. Emerging evidence suggests that chronic inflammation, often driven by specific carcinogenic exposures, plays a critical role in tumour development. While the oncogenic role of various chemical agents in UTUC is well established, the potential contribution of recurrent urolithiasis remains underappreciated and insufficiently studied. Given the frequent observation of inflammatory polyps surrounding upper tract calculi, further investigation into this association is warranted. Case presentation This case series reports on three patients with UTUC in the context of recurrent urolithiasis. Case 1 involves a 53-year-old male patient with a history of repeated ureteric stones and inflammatory polyps who was later diagnosed with low-grade invasive urothelial carcinoma. Case 2 describes a 46-year-old female patient with bilateral renal calculi who developed high-grade invasive UTUC following long-standing calculus disease. Case 3 is a 57-year-old male patient who had recently ingested herbal medicine containing aristolochic acid and was found to have high-grade UTUC, with concurrent urolithiasis potentially contributing to carcinogenesis. In each instance, urothelial carcinoma was initially concealed by polypoid lesions surrounding impacted stones, highlighting the associated diagnostic challenges.
Conclusion
This case series underscores the potential oncogenic role of chronic inflammation induced by recurrent upper urinary tract calculi. Persistent stone-related mucosal injury may contribute to UTUC pathogenesis. Clinicians should maintain a high index of suspicion and perform targeted biopsies of polypoid lesions encountered during the endoscopic management of urolithiasis. Enhanced awareness may facilitate earlier detection and intervention, particularly in patients with recurrent calculus disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
- Cancer Institute, School of Medicine, Tongji University, Shanghai, China.
- Department of Nephrology, Nantong Tongzhou District People's Hospital, Nantong, China.
- Department of Urology, Peking University First Hospital, Beijing, China.
- Department of Urology, People's Hospital of Shigatse City, Shigatse, China.
Zitieren
APA
Zhang, Y., Shen, S., Li, W., Hu, Y., Zhang, Y., Li, K., & Wang, G. (2026). Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1850083
Vancouver
Zhang Y, Shen S, Li W, Hu Y, Zhang Y, Li K, et al. Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1850083
BibTeX
@article{Zhang2026,
author = {Zhang, Yuke and Shen, Shuxian and Li, Weiyuan and Hu, Yangyang and Zhang, Yu and Li, Keqiang and Wang, Guangchun},
title = {Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1850083}
}
EUVIMED